New Frontiers in Addiction Medicine: Genetic Research and Biomarkers 

What if a simple blood test indicated the most-effective treatment medication for individuals with alcohol or opioid addiction? "Biomarker" research underway by Mayo Clinic and Hazelden Betty Ford aims to provide that very insight. Listen in as host William C. Moyers talks with addiction psychiatrist Marvin D. Seppala, MD, about how these scientific investigations at the genetic and cellular level will inform precision treatment for patients and lead to development of new addiction medications.

Listen now or read the podcast transcript to learn more about genetic research and biomarkers.